Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


AI-Focused Asia Hedge Funds Deliver Triple-Digit Returns in 2026 Rally
DOJ Clears Paramount Skydance-Warner Bros. Discovery Merger Without Conditions
China Industrial Output Beats Forecasts as Domestic Demand Weakens
Woodside Energy Denies Exxon Mobil Takeover Talks Amid LNG Growth Focus
BOJ Raises Interest Rates to 31-Year High, Signals Strong Focus on Inflation Risks
German Auto Suppliers Turn Bearish as Investment and Jobs Shift Overseas
Roku Explores Sale Options as Interest Grows in Streaming and Ad Business
U.S. Gasoline Prices Fall Below $4 as U.S.-Iran Deal Eases Oil Market Concerns
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision
U.S.-Iran Peace Deal Extends Gulf Ceasefire, Reopens Strait of Hormuz
SoftBank Vision Fund CFO Navneet Govil to Exit After Decade-Long Tenure
SpaceX Stock Gets $175 Target as Analysts See Massive Growth Ahead
Asian Markets Mixed Ahead of Key Central Bank Decisions
Gold Prices Surge Above $4,300 as US-Iran Peace Deal Weakens Dollar and Oil
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms
AI Memory Boom Sparks Global Chip Supply Crunch 



